$LFCR

LIFECORE BIOMEDICAL, INC. DE

No enriched coverage for $LFCR in the last 7 days.

No SEC Form 4 filings for $LFCR in the last 30 days.

Med

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential claims against Lifecore Biomedical, Inc. (LFCR) and certain officers/directors for alleged corporate wrongdoing. The firm encourages investors who purchased Lifecore securities before October 7, 2020, and still hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis and seeks to recover investor capital and ensure corporate accountability.

Attention Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

Grabar Law Office is investigating potential breaches of fiduciary duties by officers and directors of Ibotta, Inc., Lifecore Biomedical, Inc., Molina Healthcare, Inc., and WEBTOON Entertainment Inc. The law office is encouraging long-term shareholders of these companies, who purchased shares during specific periods, to contact them to seek corporate reforms and other remedies at no cost. The investigations stem from alleged misleading statements, internal control deficiencies, and other issues that affected the companies' financial projections and investor information.

Notice to Long-Term Shareholders of Cytokinetics, Inc.

Grabar Law Office is investigating claims on behalf of long-term shareholders of Cytokinetics, Inc. (NASDAQ: CYTK), Lifecore Biomedical, Inc. (NASDAQ: LFCR), Molina Healthcare, Inc. (NYSE: MOH), and WEBTOON Entertainment, Inc. (NASDAQ: WBTN). These investigations concern alleged breaches of fiduciary duties by officers and directors, ranging from misleading statements and delayed disclosures to deficient internal controls and misrepresentations of performance metrics. Shareholders who held shares prior to specific dates are encouraged to contact Grabar Law Office to seek corporate reforms and other remedies.